Efficacy and safety of nivolumab monotherapy in patients with metastatic urothelial cancer (mUC) who have received prior treatment: Results from the phase II CheckMate 275 study
暂无分享,去创建一个
E. Plimack | P. Sharma | M. Grimm | C. Ohyama | A. Necchi | S. Pal | A. Siefker-Radtke | J. Bedke | A. Saci | M. Retz | S. Bracarda | A. Baron | A. Lambert | S. Krishnan | D. Vaena | J. A. Arija | Alex Azrilevich | Galsky